Gini Fleming

17PUBLICATIONS
100CO-AUTHORS
Predictive and prognostic markersSolid tumoursHaematologyAir pollution modelling and controlCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 24, 2026
Ovarian cancer cell glucocorticoid receptor activation increases myeloid-derived suppressor cell tumor infiltration.

Manisha Taya, Eleanore Gray, Tryambak Srivastava

|May 22, 2025
Early-Phase Trials in Journal of Clinical Oncology.

Thomas E Stinchcombe, Gini F Fleming, Charles Craddock

|Mar 14, 2025
Reply to: Reflections on the HORSE Trial: Hyperthermic Intraperitoneal Chemotherapy, BRCA Status, and Clinical Implications.

Gini F Fleming

|Jan 24, 2025
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.

Stephen J Luen, Lauren C Brown, Courtney T van Geelen

|Sep 11, 2024
Combining Response and Toxicity Data to Implement Project Optimus.

Robert G Maki, Thomas E Stinchcombe, Gary K Schwartz

|Jun 23, 2024
Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models.

Manisha Taya, Xiaonan Hou, Jennifer T Veneris

Pageof 3

Frequent Collaborators

3 joint publications

Prudence A Francis

3 joint publications

Alan S Coates

3 joint publications

Meredith M Regan

3 joint publications

Sherene Loi